Vertex Pharmaceuticals Incorporated
VRTX
$387.18
-$1.76-0.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.93% | 1.39% | -6.26% | 12.58% | -43.02% |
| Total Receivables | 4.90% | 12.16% | -8.07% | 5.71% | -7.65% |
| Inventory | 10.27% | 12.80% | 11.63% | 18.06% | 12.48% |
| Prepaid Expenses | 10.02% | 26.66% | 4.67% | -16.99% | 11.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -79.74% | -70.36% | 1,866.67% | -77.61% | 24.40% |
| Total Current Assets | 4.19% | 4.30% | -2.12% | 9.65% | -32.71% |
|
|
|||||
| Total Current Assets | 4.19% | 4.30% | -2.12% | 9.65% | -32.71% |
| Net Property, Plant & Equipment | 0.55% | 1.93% | 2.81% | 41.97% | 19.18% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.29% | -46.58% | -0.69% | -0.70% | 0.31% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.80% | 6.78% | 1.26% | 6.93% | 9.10% |
| Total Assets | 5.05% | 1.54% | 1.32% | 10.47% | -15.83% |
|
|
|||||
| Total Accounts Payable | -0.61% | 7.75% | 4.35% | 20.71% | -6.69% |
| Total Accrued Expenses | 10.80% | 12.34% | -18.39% | 9.51% | 5.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 29.63% | -- | -- |
| Total Finance Division Other Current Liabilities | 10.09% | -10.51% | 50.77% | 2.54% | -56.94% |
| Total Other Current Liabilities | 10.09% | -10.51% | 50.77% | 2.54% | -56.94% |
| Total Current Liabilities | 9.39% | 6.13% | -10.28% | 12.01% | -6.55% |
|
|
|||||
| Total Current Liabilities | 9.39% | 6.13% | -10.28% | 12.01% | -6.55% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.38% | -0.49% | -2.68% | 82.44% | 29.41% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.59% | 5.56% | -3.38% | 6.44% | 2.72% |
| Total Liabilities | 7.47% | 4.26% | -7.35% | 23.37% | -0.25% |
|
|
|||||
| Common Stock & APIC | -2.99% | -7.49% | -3.38% | -2.75% | -2.52% |
| Retained Earnings | 10.07% | 6.73% | 10.50% | 13.67% | -31.97% |
| Treasury Stock & Other | -248.46% | -46.71% | 343.75% | 28.00% | 30.06% |
| Total Common Equity | 4.12% | 0.53% | 4.98% | 5.80% | -20.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.12% | 0.53% | 4.98% | 5.80% | -20.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.12% | 0.53% | 4.98% | 5.80% | -20.34% |
|
|
|||||